DBV Technologies S.A. logo
DBV Technologies S.A. DBVT
$ 18.28 7.47%

Quarterly report 2025-Q2
added 07-29-2025

report update icon

DBV Technologies S.A. Total Current Liabilities 2011-2026 | DBVT

Annual Total Current Liabilities DBV Technologies S.A.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
31.1 M 37.3 M 29.5 M 31.4 M 52.7 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
52.7 M 29.5 M 36.4 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Adagene Adagene
ADAG
38.2 M $ 1.65 7.91 % $ 92.9 M chinaChina
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.52 -16.3 % $ 388 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Biogen Biogen
BIIB
5.53 B $ 184.48 -1.67 % $ 26.9 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.05 M $ 4.25 1.67 % $ 9.25 B israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Catalyst Biosciences Catalyst Biosciences
CBIO
20 M $ 10.84 0.46 % $ 714 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
72.8 M - -15.15 % $ 60.3 M britainBritain
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
141 M $ 37.35 -0.4 % $ 3.86 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
54.1 M - - $ 1.01 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
121 M $ 23.18 2.02 % $ 2.75 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
39.5 M $ 25.59 -6.54 % $ 1.65 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
174 M $ 29.43 6.09 % $ 1.43 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
195 M $ 66.05 2.3 % $ 8.83 B usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
59.7 M $ 55.11 3.49 % $ 4.45 B usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
13.4 M $ 5.14 -1.06 % $ 110 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
87.8 M $ 55.17 2.47 % $ 4.65 B schweizSchweiz
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Axon Enterprise Axon Enterprise
AXON
1.68 B $ 632.29 0.09 % $ 47.9 B usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
23.4 M $ 0.81 1.96 % $ 10.7 K usaUSA
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.7 2.27 % $ 17 M usaUSA